Cargando…

Bacteriophage Procurement for Therapeutic Purposes

Bacteriophages (phages), discovered 100 years ago, are able to infect and destroy only bacterial cells. In the current crisis of antibiotic efficacy, phage therapy is considered as a supplementary or even alternative therapeutic approach. Evolution of multidrug-resistant and pandrug-resistant bacter...

Descripción completa

Detalles Bibliográficos
Autores principales: Weber-Dąbrowska, Beata, Jończyk-Matysiak, Ewa, Żaczek, Maciej, Łobocka, Małgorzata, Łusiak-Szelachowska, Marzanna, Górski, Andrzej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4981656/
https://www.ncbi.nlm.nih.gov/pubmed/27570518
http://dx.doi.org/10.3389/fmicb.2016.01177
_version_ 1782447641892749312
author Weber-Dąbrowska, Beata
Jończyk-Matysiak, Ewa
Żaczek, Maciej
Łobocka, Małgorzata
Łusiak-Szelachowska, Marzanna
Górski, Andrzej
author_facet Weber-Dąbrowska, Beata
Jończyk-Matysiak, Ewa
Żaczek, Maciej
Łobocka, Małgorzata
Łusiak-Szelachowska, Marzanna
Górski, Andrzej
author_sort Weber-Dąbrowska, Beata
collection PubMed
description Bacteriophages (phages), discovered 100 years ago, are able to infect and destroy only bacterial cells. In the current crisis of antibiotic efficacy, phage therapy is considered as a supplementary or even alternative therapeutic approach. Evolution of multidrug-resistant and pandrug-resistant bacterial strains poses a real threat, so it is extremely important to have the possibility to isolate new phages for therapeutic purposes. Our phage laboratory and therapy center has extensive experience with phage isolation, characterization, and therapeutic application. In this article we present current progress in bacteriophages isolation and use for therapeutic purposes, our experience in this field and its practical implications for phage therapy. We attempt to summarize the state of the art: properties of phages, the methods for their isolation, criteria of phage selection for therapeutic purposes and limitations of their use. Perspectives for the use of genetically engineered phages to specifically target bacterial virulence-associated genes are also briefly presented.
format Online
Article
Text
id pubmed-4981656
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-49816562016-08-26 Bacteriophage Procurement for Therapeutic Purposes Weber-Dąbrowska, Beata Jończyk-Matysiak, Ewa Żaczek, Maciej Łobocka, Małgorzata Łusiak-Szelachowska, Marzanna Górski, Andrzej Front Microbiol Microbiology Bacteriophages (phages), discovered 100 years ago, are able to infect and destroy only bacterial cells. In the current crisis of antibiotic efficacy, phage therapy is considered as a supplementary or even alternative therapeutic approach. Evolution of multidrug-resistant and pandrug-resistant bacterial strains poses a real threat, so it is extremely important to have the possibility to isolate new phages for therapeutic purposes. Our phage laboratory and therapy center has extensive experience with phage isolation, characterization, and therapeutic application. In this article we present current progress in bacteriophages isolation and use for therapeutic purposes, our experience in this field and its practical implications for phage therapy. We attempt to summarize the state of the art: properties of phages, the methods for their isolation, criteria of phage selection for therapeutic purposes and limitations of their use. Perspectives for the use of genetically engineered phages to specifically target bacterial virulence-associated genes are also briefly presented. Frontiers Media S.A. 2016-08-12 /pmc/articles/PMC4981656/ /pubmed/27570518 http://dx.doi.org/10.3389/fmicb.2016.01177 Text en Copyright © 2016 Weber-Dąbrowska, Jończyk-Matysiak, Żaczek, Łobocka, Łusiak-Szelachowska and Górski. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Weber-Dąbrowska, Beata
Jończyk-Matysiak, Ewa
Żaczek, Maciej
Łobocka, Małgorzata
Łusiak-Szelachowska, Marzanna
Górski, Andrzej
Bacteriophage Procurement for Therapeutic Purposes
title Bacteriophage Procurement for Therapeutic Purposes
title_full Bacteriophage Procurement for Therapeutic Purposes
title_fullStr Bacteriophage Procurement for Therapeutic Purposes
title_full_unstemmed Bacteriophage Procurement for Therapeutic Purposes
title_short Bacteriophage Procurement for Therapeutic Purposes
title_sort bacteriophage procurement for therapeutic purposes
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4981656/
https://www.ncbi.nlm.nih.gov/pubmed/27570518
http://dx.doi.org/10.3389/fmicb.2016.01177
work_keys_str_mv AT weberdabrowskabeata bacteriophageprocurementfortherapeuticpurposes
AT jonczykmatysiakewa bacteriophageprocurementfortherapeuticpurposes
AT zaczekmaciej bacteriophageprocurementfortherapeuticpurposes
AT łobockamałgorzata bacteriophageprocurementfortherapeuticpurposes
AT łusiakszelachowskamarzanna bacteriophageprocurementfortherapeuticpurposes
AT gorskiandrzej bacteriophageprocurementfortherapeuticpurposes